Skip to main content

Table 3 Results of cox regression multivariate 5-year survival analysis of the patients with non-small cell lung cancer

From: Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer

 

B

SE

Wald

P

HR

95.0% CI for HR

Gender

0.573

0.409

1.968

0.161

1.774

0.796–3.951

Age

− 0.332

0.372

0.796

0.372

0.718

0.346–1.488

Somking

− 0.079

0.467

0.029

0.865

0.924

0.370–2.307

Histological type

− 0.755

0.436

1.335

0.248

1.424

0.782–2.594

Differentiation

0.353

0.306

2.757

0.097

1.707

0.908–3.209

pT

0.455

0.390

1.357

0.244

1.576

0.733–3.387

pN

1.948

0.656

8.805

0.003

7.011

1.937–25.379

pTNM

0.055

0.401

0.019

0.890

1.057

0.482–2.318

Chemotherapy

− 0.749

0.576

1.692

0.193

0.473

0.153–1.462

Radiotherapy

0.257

0.381

0.455

0.500

1.293

0.613–2.726

EGFR-TKI therapy

− 0.072

0.503

0.020

0.8587

0.931

0.348–2.493

KIF21B

0.900

0.439

5.081

0.0040

2.460

1.041–5.811

  1. B regression coefficient, SE standard error, Wald Wald value, HR hazard ratio, CI confidence interval
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us